Eurasian – American Innovation Technology Week Seminar Sessions at the Hermes Expo

Globalization of clinical trials is the result of the U.S. Pharma business actively entering international markets, demand for higher patient population size, ICH-GCP principles implementation worldwide, cost effectiveness, and many other reasons. Among all the regions, emerging markets such as China, Brazil, India, Asia Pacific, Russia and Eastern Europe became very popular to place clinical studies.

Last week Nataliya Katsnelson, GCT Senior Business Development Manager presented on the topic of acceptance of the data from foreign investigations by the U.S. FDA during 22nd Annual Eurasian – American Innovation Technology Week (RANIT) Seminar Sessions at the Hermes Expo.

GCT would like to thank the organizer of series regional industry events, the Mid-Atlantic – Eurasia Business Council President Val Kogan

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2018 Global Clinical Trials, LLC

All rights reserved.